{"result": "(\"entity\"<|>SDHB<|>PERSON<|>SDHB is a gene associated with pheochromocytoma and paraganglioma, with mutations leading to metastatic disease in some cases.)\n##\n(\"entity\"<|>SDHD<|>PERSON<|>SDHD is a gene that is typically mutated in head and neck paragangliomas and is subject to maternal imprinting.)\n##\n(\"entity\"<|>SDHAF2<|>PERSON<|>SDHAF2 is a gene associated with paragangliomas, particularly in the context of familial syndromes.)\n##\n(\"entity\"<|>SDHC<|>PERSON<|>SDHC is a gene that can be involved in the development of paragangliomas and pheochromocytomas.)\n##\n(\"entity\"<|>NEOPLASIA ENDOCRINA MÚLTIPLE TIPO 2-A<|>EVENT<|>Neoplasia Endocrina Múltiple Tipo 2-A is a genetic disorder that includes pheochromocytoma as one of its manifestations.)\n##\n(\"relationship\"<|>SDHB<|>FEOCROMOCITOMA<|>Mutations in the SDHB gene can lead to the development of pheochromocytoma<|>6)\n##\n(\"relationship\"<|>SDHD<|>PARAGANGLIOMA<|>Mutations in the SDHD gene are commonly associated with head and neck paragangliomas<|>6)\n##\n(\"relationship\"<|>SDHAF2<|>PARAGANGLIOMA<|>SDHAF2 mutations are linked to familial paragangliomas<|>6)\n##\n(\"relationship\"<|>SDHC<|>PARAGANGLIOMA<|>Mutations in the SDHC gene can contribute to the development of paragangliomas<|>6)\n##\n(\"relationship\"<|>NEOPLASIA ENDOCRINA MÚLTIPLE TIPO 2-A<|>FEOCROMOCITOMA<|>Neoplasia Endocrina Múltiple Tipo 2-A includes pheochromocytoma as a clinical feature<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: preparación médica adecuada en to-\n         dos los pacientes. El tratamiento preoperatorio incluye siempre un control adecuado de las                                            Aproximadamente, el             10% de los feocromocitomas y hasta un 20-25% de los paragan-\n         crisis hipertensivas y una             adecuada expansión de volumen. El bloqueo                            alfaadrenérgico           gliomas son malignos. Se considera maligno cuando produce invasión local, metástasis\n         debe iniciarse 10 a 14 días antes de la cirugía, siendo la fenoxibenzamida el tratamiento                                             a distancia      o recurrencias, lo cual puede ocurrir hasta                    20 años tras la resección del tumor.\n         de elección. No puede olvidarse que                    el  bloqueo       betaadrenérgico          nunca      puede     iniciarse      Las   mutaciones en el gen              SDHB dan lugar a enfermedad metastásica hasta en el 40% de\n         en primer lugar para no exponer al paciente a mayores niveles de catecolaminas sobre los                                              los casos.\n         receptores alfaadrenérgicos y provocarle crisis hipertensivas.                                                                        La neoplasia endocrina múltiple tipo 2-A es un trastorno autosómico dominante con pene-\n                                                                                                                                               trancia relacionada con la edad. El fenotipo MEN2A incluye el feocromocitoma suprarrenal\n                                                                                                                                               (habitualmente         bilateral y que puede           ser asíncrono),        el carcinoma medular de tiroides                 y el\n                                                                                                                                               hiperparatiroidismo primario.\n\n\n\n282                                                                                                                                                                                                                                                                                   283\n---\n                                                                                                                                                                                                                      SUPRARRENALES                                        5\n\n\n\n         Aunque     se prefiere que los pacientes no reciban ninguna medicación durante la evaluación                                        Las mutaciones en SDHD, SDHAF2 y SDHC son típicas de los paragangliomas de cabeza\n         diagnóstica, se puede continuar el tratamiento con la mayoría de los fármacos. Los antide-                                          y cuello y están sujetas por           el fenómeno de impronta materna (si la mutación es heredada\n         presivos tricíclicos        interfieren con mayor frecuencia en la interpretación de catecolaminas                                  de la madre no se manifiesta y tiene alta penetrancia si se hereda del padre). Los                               pacientes\n         y metanefrinas en orina de 24 horas (aumentan su valor) y se recomienda disminuir la dosis                                          con mutaciones en SDHB presentan más a menudo paragangliomas en tórax y abdomen\n         o suspender por lo menos 2 semanas antes de las pruebas hormonales.                                                                 y en hasta un 50% de los casos metástasis a distancia.\n         Referencias:                                                                                                                        Un hallazgo interesante en relación con el tipo de mutaciones en SDHB y SDHD es que las\n         • Díaz Pérez JA, Crespo Hernández I. Feocromocitoma y paraganglioma. Manual de Endocrinología y Nutrición. Disponible en:           mutaciones de sentido erróneo o missense son relativamente más frecuentes que las mu-\n           https://manual.seen.es (última modificación: 24 de noviembre de 2015).\n         • Lenders JWM, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SKG, Murad MH, et al. Pheochromocytoma and paraganglioma:           taciones que producen un codon de parada y dan lugar a una proteína truncada en SDHB,\n           an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2014;99:1915-41.                                       mientras que en SDHD son más frecuentes las mutaciones que producen                                         una proteína\n         • Neumann HPH. Feocromocitoma. En: Kasper DL, Hauser SL, Jameson JL, Fauci AS, Longo DL, Loscazo J, eds. Harrison Principios        truncada.\n           de Medicina Interna. 19.ª edición en español. México DF: Mc Graw Hill; 2016. p. 2329-35.\n         • Young WF, Jr. Clinical presentation and diagnosis of pheochromocytoma. UpToDate. Waltham, MA: UpToDate Inc. https://www.\n           uptodate.com. Literature review current through: Apr. 2019.                                                                       Referencias:\n         • Young WF, Jr. Endocrine Hypertension. En: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams Textbook                 • Díaz Pérez JA, Crespo Hernández I. Feocromocitoma y paraganglioma. Manual de Endocrinología y Nutrición. Disponible en:\n           of Endocrinology. 13.ª ed. Philadelphia: Elsevier; 2016. p. 556-88.                                                                 https://manual.seen.es (última modificación: 24 de noviembre de 2015).\n         • Young WF, Jr, Kebebew E. Treatment of pheochromocytoma in adults. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>FEOCROMOCITOMA<|>EVENT<|>Feocromocitoma is a type of tumor that can cause hypertension and is often treated with specific preoperative medications.)\n##\n(\"entity\"<|>PARAGANGLIOMA<|>EVENT<|>Paraganglioma is a tumor related to the nervous system that can also lead to hypertension and may have genetic mutations associated with it.)\n##\n(\"entity\"<|>DÍAZ PÉREZ JA<|>PERSON<|>Díaz Pérez JA is an author who contributed to the manual on endocrinology and nutrition discussing pheochromocytoma and paraganglioma.)\n##\n(\"entity\"<|>CRESPO HERNÁNDEZ I<|>PERSON<|>Crespo Hernández I is an author who co-wrote the manual on endocrinology and nutrition discussing pheochromocytoma and paraganglioma.)\n##\n(\"entity\"<|>UPTODATE INC<|>ORGANIZATION<|>UpToDate Inc. is a medical information provider that offers guidelines and literature reviews on various medical conditions, including pheochromocytoma.)\n##\n(\"entity\"<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>ORGANIZATION<|>Harrison's Principles of Internal Medicine is a comprehensive medical textbook that includes information on pheochromocytoma.)\n##\n(\"relationship\"<|>DÍAZ PÉREZ JA<|>CRESPO HERNÁNDEZ I<|>Díaz Pérez JA and Crespo Hernández I co-authored a manual discussing pheochromocytoma and paraganglioma<|>7)\n##\n(\"relationship\"<|>FEOCROMOCITOMA<|>PARAGANGLIOMA<|>Feocromocitoma and paraganglioma are both types of tumors that can cause similar symptoms and are discussed in the same medical context<|>5)\n##\n(\"relationship\"<|>UPTODATE INC<|>FEOCROMOCITOMA<|>UpToDate Inc. provides clinical practice guidelines for the diagnosis and treatment of pheochromocytoma<|>8)\n##\n(\"relationship\"<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>FEOCROMOCITOMA<|>Harrison's Principles of Internal Medicine includes detailed information on pheochromocytoma<|>8)\n<|COMPLETE|>"}]}